Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)
Volume 96 | IMPE2023

IMPE 2023

Buenos Aires, Argentina
04 Mar 2023 - 07 Mar 2023

Card image cap
11th International Meeting of Pediatric Endocrinology (IMPE 2023). 4 -7 March 2023 - Buenos Aires, Argentina.

ePoster Presentations

Growth and Syndromes

impe0096ep47 | Growth and Syndromes | IMPE2023

A novel CNOT1 gene frameshift mutation causes Vissers-Bodmer syndrome

Wu Tingting , Zhang Xianxu , Ahamada Mariame , Zheng Songjia , Yi Ping , Zhang Xingxing

Purpose: Vissers-Bodmer Syndrome is an autosomal dominant disorder caused by CNOT1 gene mutation. It is characterized by systemic developmental delay, mental retardation, language-motor retardation, behavioral abnormalities, growth abnormalities, hypotonia, and distal skeletal defects such as deformities of the hands and feet, It’s evident from infancy. The phenotype is highly variable, with some people having only mild learning difficulties and others h...

impe0096ep48 | Growth and Syndromes | IMPE2023

Wiedemann-Steiner Syndrome: Case-report and review of literature

Yu Huan , Wu Wei

Wiedemann-Steiner Syndrome (WDSTS) is an autosomal dominant disorder with a broad and variable spectrum, characterized by intellectual disability (ID), prenatal and postnatal growth retardation, hypertrichosis, characteristic facial features, behavioral problems, and congenital anomalies involving different systems. A total of three patients were diagnosed with novel pathogenic mutations in the KMT2A gene in our hospital. Our first patient was a 15-month-old girl found by Trio...

impe0096ep49 | Growth and Syndromes | IMPE2023

Contiguous gene syndrome involving multisystem diseases characterized by short stature

Valeri Clara , Luz Solano Lopez Alba , Urman Gabriela , Goldschmidt Ernesto , Ercoli Gabriel

We describe a female patient with a contiguous gene deletion and duplication syndrome encompassing 223 genes, only manifesting features of BLM (Bloom Syndrome), AGLB1 (Fuchs' dystrophy) and ACAN (Aggreccan Gene Mutation). Our study was started with the observation and follow-up of a 8-year-old pre-term child with short stature (-2.8SD), a peculiar phenotype, microcephaly, ogival palate, short neck, wide nasal bridge, bushy eyebrows and eyelashes, scoliosis, umbilical hern...

impe0096ep50 | Growth and Syndromes | IMPE2023

Assessment of growth and ventilatory sleep disorders in Prader Willi Syndrome patients with early onset of recombinant growth hormone treatment.

Troiano Marina , Fittipaldi Yamila , Pereyra Carla , Kuspiel Florencia , Pasqualini Titania , Alonso Guillermo

Natural history of Prader-Willi syndrome (PWS) is greatly improved when recombinant growth hormone (rGH) treatment is started early in life, turning out to be effective and safe. However, safety alerts persists in relation to possible ventilatory effects of rGH treatment in the first months. For this reason clinical guidelines recommend close monitoring by specialists in sleep-related disordered breathing and otorhinolaryngologists.Objective:</st...

impe0096ep51 | Growth and Syndromes | IMPE2023

Glucose metabolism in patients with short stature born small for gestational age (SGA) or with intrauterine growth restriction (IUGR) treated with recombinant human growth hormone (rhGH)

Morales Cintia , Celeste Mattone María , Krochick Gabriela , Ciaccio Marta , Guercio Gabriela

Background: Children born SGA/IUGR are at increased risk of long term endocrine-metabolic disorders. In addition, treatment with supra-physiological doses of rhGH in those without postnatal catch-up growth is associated with insulin resistance. However, studies evaluating glucose metabolism (GM) under rhGH treatment showed variable results.Objectives: To analyze GM in SGA/IUGR patients with short stature in basal conditions and under rhG...

impe0096ep52 | Growth and Syndromes | IMPE2023

Ring Chromosome 17 Syndrome and its Growth Hormone Response: A Case Report

Tempone Cardoso Penna Gustavo , de Rezende Lelot Gabriela , Luiza de Rezende Lelot Ana , Greghi Hernandez Juliana , Costa Figueiredo Carolina , Michelle de Araújo Evangelista Nara , de Fátima Tonetto Fernandes Vânia , de Paula Colares Neto Guido

Introduction: Ring chromosome 17 syndrome has a variable phenotype depending on the number of genes lost, gene regulation, and mosaicism degree.Case Report: Scholar, male, presents typical ring chromosome 17 syndrome characteristics, without Miller-Dicker’s critical region involvement, with short stature, moderate left conductive deafness, left kidney hypoplasia, seizures, abdomen malformations, that was confirmed ...

impe0096ep53 | Growth and Syndromes | IMPE2023

A novel CEP57 variant associated with mosaic variegated aneuploidy syndrome type 2

Wu Tingting , Zhang Xianxu , Zheng Songjia , Yi Ping , Zhang Xingxing

Purpose: Mosaic variegated aneuploidy syndrome type 2(MVA2) is a rare, autosomal recessive genetic disease characterized by mosaic aneuploidies involving multiple chromosomes and tissues, caused by biallelic pathogenic variants in the CEP57 gene. Patients usually present with intrauterine growth retardation, postnatal growth and developmental disorders, microcephaly, special facial features, congenital heart disease, etc. Only 13 cases of patients carrying the...

impe0096ep54 | Growth and Syndromes | IMPE2023

A rare homozygous IGFALS gene pathogenic variant: a case report.

Della Pia Belén , Colombres Maria Jose , Insua Claudia , Alejandra Scaglia Paula , Azcoiti Maria Esnaola , Brunetto Oscar , Hernandez Claudia

Introduction: Acid-labile subunit (ALS) forms ternary complexes with insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) being essential for normal circulating IGF-1 levels. The IGFALS gene encodes the ALS and loss-of-function variants in IGFALS cause ALS deficiency, which has a prevalence < 1/1.000.000. These patients generally present with moderate short stature, extraordinarily low serum levels of IGF-I and IGFBP-3 ...

impe0096ep55 | Growth and Syndromes | IMPE2023

Genotype and Clinical Characteristics Analysis of a Short Stature Patient with HUWE1 Gene Variants

Chunyan Cai , Ruimin Chen

Objective: To analyze the clinical manifestations and genetic characteristics of X-linked intellectual disability (XLID). Methods: The clinical data of a boy with XLID were retrospectively analyzed. The Clinical and gene mutation characteristics of XLID were summarized by a literature review. The whole exome-sequencing test was used to analyze the gene mutation. The pathogenicity of novel mutations was analyzed and the changes of protein function resulted from...

impe0096ep56 | Growth and Syndromes | IMPE2023

Noonan syndrome: a cause of short stature with cardiac manifestations and characteristic facial phenotype

Cristina Martinez Rueda Silvia , del Pilar Montilla Velasquez Maria , Victoria Lopera Cañaveral Maria , Pineda Trujillo Nicolas , Camilo Martinez Salgado Juan , Gomez Rojas Susana

The Noonan syndrome (NS) is part of the rasopathies. Rasopathies are autosomal dominant and recessive disorders due to mutations in genes encoding components or regulators of the RAS/mitogen-activated protein kinase (MAPK) signal transduction pathway, which is essential for cell cycle differentiation, growth, and senescence This syndrome presents three cardinal characteristics: distinctive facial features, postnatal short stature, and cardiac abnormalities. NS coexists with mi...

impe0096ep57 | Growth and Syndromes | IMPE2023

Long term follow-up of a child with McCune Albright syndrome

Simunovic Marko , Skrabic Veselin

Introduction: McCune Albright syndrome is diagnosed by classical clinical manifestations of cafe au lait skin macules, multiple endocrinopathies and fibrous dysplasia of bones. The prevalence of syndrome is estimated at 1 in 100,000 to 1 in 100,000,000. McCune Albright syndrome is caused by a postzygotic mutation of the GNAS gene, which results in great variability in clinical presentation. The most common endocrine manifestation is premature puberty, but hype...

impe0096ep58 | Growth and Syndromes | IMPE2023

Isolated growth hormone deficiency related to GH1 gene deletion: Case report and response to treatment with rhIGF1

Cespedes Camila , Forero Catalina

Growth hormone deficiency is an entity that can affect 1/3480 children. Its etiology can be congenital or acquired. Within the congenital forms of isolated growth hormone deficiency, there are those related to the alteration of the gene that encodes it. They constitute a rare subgroup of pathologies whose inheritance pattern can be autosomal recessive, dominant or X linked. The mechanisms of growth alteration vary between those that affect the expression of the GH 1 gene, and ...